Regarding respiratory symptoms as one of the main clinical manifestations of COVID-19, IgA antibodies have a higher sensitivity, while IgG antibodies are more durable, specific, and might be better suited for serosurveillance studies [17,18]. Here, CD79A is linked to COVID-19.